Page 34 - Loss Attributable News Today

Confirm Initiated Phase 1b/2a Clinical Trial of SYN-004 in Allogeneic HCT Recipients for the Prevention of aGVHD Initiated Phase 1a Single-Ascending-Dose Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase Reports $76.9 Million of Cash on Hand to Fund Clinical Programs Through Proof-of-Concept and Extend Operations into 2023 -- Conference Call Today at 4:30 p.m. (ET) -- PR Newswire ROCKVILLE, Md., May 5, 2021 ROCKVILLE, Md., May 5, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYS...

GigaMedia Announces First-Quarter 2021 Financial Results GigaMedia Limited today announced its first quarter 2021 unaudited financial results. Comments from Management For the first quarter of 2021, GigaMedia reported revenues of $1.45 million with a gross profit of $0.79 million an operating loss of $0.90 million and the net loss of $0.88 million . Total revenues increased by 2.0% if compared to the previous quarter. “Our business momentum has slowed since the fourth … GigaMedia Limited (N...

Share: Southampton, Pennsylvania, May 03, 2021 (GLOBE NEWSWIRE) -- Quaint Oak Bancorp, Inc. (the "Company") (OTCQB:QNTO), the holding company for Quaint Oak Bank (the "Bank"), announced today that net income for the quarter ended March 31, 2021 was $1.0 million, or $0.52 per basic and $0.50 per diluted share, compared to $432,000, or $0.22 per basic and $0.21 per diluted share for the same period in 2020. Robert T. Strong, President and Chief Executive Officer stated, "It is my pleasure to pr...

Peabody Reports Results For Quarter Ended March 31, 2021 News provided by Share this article Share this article ST. LOUIS, April 29, 2021 /PRNewswire/ -- Peabody (NYSE: BTU) today announced its first quarter 2021 operating results, including revenues of $651.3 million; loss from continuing operations, net of income taxes of $77.7 million; net loss attributable to common stockholders of $80.1 million; diluted loss per share from continuing operations of $0.79; and Adjusted EBITDA 1 of $61.1 mil...

$0.98 NOTE: For more information regarding these non-GAAP adjustments, see the footnotes accompanying the Financial Highlights page of the earnings package. Earnings drivers for the first quarter of 2021, as compared with 2020, were robust customer growth, higher residential sales and colder weather, partially offset by lower commercial and industrial sales. "Southern Company experienced a strong start to the year," said Chairman, President and CEO, Thomas A. Fanning. "The economies in our se...

Stepan Reports Record Quarterly Earnings News provided by Share this article First Quarter Highlights Reported net income was a record $40.6 million, or $1.74 per diluted share versus $27.5 million, or $1.18 per diluted share, in the prior year. Adjusted net income* was a record $42.4 million, or $1.82 per diluted share versus $24.2 million, or $1.04 per diluted share, in the prior year. Total Company sales volume increased 6% versus the prior year. Surfactant operating income was $53.2 millio...

TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2021 News provided by Share this article Net Revenues up by 58.9% Year-Over-Year for the Fourth Fiscal Quarter Non-GAAP Loss from Operations was US$216.9 million, compared to Non-GAAP Loss from Operations of US$8.4 million in the Same Period of Prior Year Total Student Enrollments of Normal Priced Long-term Course up by 44.0% Year-Over-Year Fiscal Year Results: Non-GAAP Loss from Operatio...

RISE Education Announces Fourth Quarter and Full Year 2020 Unaudited Financial Results News provided by Share this article Share this article BEIJING, March 16, 2021 /PRNewswire/ -- RISE Education Cayman Ltd ("RISE" or the "Company") (NASDAQ: REDU), a leading junior English Language Training ("ELT") provider in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2020. Impact of COVID-19 The outbreak of COVID-19 in late January 2020 h...

(4)% Daniel S. Jaffee, President and Chief Executive Officer, stated, “We delivered another solid quarter of topline growth and set a record for second quarter consolidated net sales. This successful performance demonstrates our dedicated focus on two primary growth drivers of our business, mineral-based animal feed additives and lightweight cat litter. With the addition of new leadership, sales personnel, and a renewed marketing strategy, we experienced a significant increase in demand for o...

Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results -- Announced Washington University Has Begun Screening Patients for Enrollment in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients -- -- Reports $72.6M of Cash on Hand to Fund Clinical Programs and Extend Operations into 2023 -- -- Conference Call Today at 4:30 p.m. (ET) -- News provided by Share this article Share this article ROCKVILLE, Md., March 4, ...